Search research articles
Contact Us
Filters
Showing results (1-10 of 54) with videos related to
Page
of 6
Sort By:
Expert Opinion on Drug Delivery
|
January 13, 2011
Upcoming therapeutic advances in diabetic macular edema: an intravitreal dexamethasone drug delivery system
Albert J Augustin
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|
April 12, 2003
[Cataract prevention. Prophylaxis with side effect?]
Albert J Augustin
Retina (Philadelphia, Pa.)
|
August 13, 2008
The physiology of scotopic vision, contrast vision, color vision, and circadian rhythmicity: can these parameters be influenced by blue-light-filter lenses?
Albert J Augustin
Expert Opinion on Therapeutic Targets
|
May 22, 2009
Inflammation and the pathogenesis of age-related macular degeneration
Albert J Augustin, Janna Kirchhof
Expert Opinion on Emerging Drugs
|
October 27, 2006
Emerging drugs for age-related macular degeneration
Albert J Augustin, Indre Offermann
Ophthalmology and Therapy
|
December 3, 2025
Letter to the Editor Regarding "Safety, Tolerability, and Short-Term Efficacy of Low-Level Light Therapy for Dry Age-Related Macular Degeneration"
Albert J Augustin, Michael Koss
Drugs & Aging
|
November 21, 2007
Combination therapy for choroidal neovascularisation
Albert J Augustin, Indre Offermann
Diagnostics (Basel, Switzerland)
|
February 25, 2022
The Value of Optical Coherence Tomography Angiography (OCT-A) in Neurological Diseases
Albert J Augustin, Jenny Atorf
Journal of Cataract and Refractive Surgery
|
March 20, 2004
Oxidative tissue damage after phacoemulsification: influence of ophthalmic viscosurgical devices
Albert J Augustin, H Burkhard Dick
Ophthalmology
|
December 20, 2005
Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration
Albert J Augustin, Ursula Schmidt-Erfurth
Page
of 6
Search research articles
Search
Showing results (1-10 of 54) with videos related to
Sort By:
Page
of 6
Expert Opinion on Drug Delivery
|
January 13, 2011
Upcoming therapeutic advances in diabetic macular edema: an intravitreal dexamethasone drug delivery system
Albert J Augustin
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|
April 12, 2003
[Cataract prevention. Prophylaxis with side effect?]
Albert J Augustin
Retina (Philadelphia, Pa.)
|
August 13, 2008
The physiology of scotopic vision, contrast vision, color vision, and circadian rhythmicity: can these parameters be influenced by blue-light-filter lenses?
Albert J Augustin
Expert Opinion on Therapeutic Targets
|
May 22, 2009
Inflammation and the pathogenesis of age-related macular degeneration
Albert J Augustin, Janna Kirchhof
Expert Opinion on Emerging Drugs
|
October 27, 2006
Emerging drugs for age-related macular degeneration
Albert J Augustin, Indre Offermann
Ophthalmology and Therapy
|
December 3, 2025
Letter to the Editor Regarding "Safety, Tolerability, and Short-Term Efficacy of Low-Level Light Therapy for Dry Age-Related Macular Degeneration"
Albert J Augustin, Michael Koss
Drugs & Aging
|
November 21, 2007
Combination therapy for choroidal neovascularisation
Albert J Augustin, Indre Offermann
Diagnostics (Basel, Switzerland)
|
February 25, 2022
The Value of Optical Coherence Tomography Angiography (OCT-A) in Neurological Diseases
Albert J Augustin, Jenny Atorf
Journal of Cataract and Refractive Surgery
|
March 20, 2004
Oxidative tissue damage after phacoemulsification: influence of ophthalmic viscosurgical devices
Albert J Augustin, H Burkhard Dick
Ophthalmology
|
December 20, 2005
Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration
Albert J Augustin, Ursula Schmidt-Erfurth
Page
of 6